Trials in Baltimore, Maryland
Here are the top 10 medical studies for lung cancer in Baltimore, Maryland
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Trastuzumab Deruxtecan for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Silver Spring, Maryland
This trial will compare the effectiveness and safety of Trastuzumab Deruxtecan to the current standard of care for treating non-small cell lung cancer with HER2 Exon 19 or 20 mutations.
Immunostimulant
Combination Immunotherapy for Lung Cancer
Recruiting1 awardPhase 2 & 3
Washington, District of Columbia
This trial is testing a new combination of treatments for patients with advanced lung cancer. The treatments aim to boost the immune system's ability to fight cancer and prevent it from growing. The goal is to see if this combination can help patients live longer compared to standard treatments.
Trials With No Placebo
Combination Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial is testing a new cancer treatment that uses two drugs, one to attack the cancer and one to boost the immune system. The goal is to see if this treatment is safe and effective.
Monoclonal Antibodies
Tarlatamab for Small Cell Lung Cancer
Recruiting1 awardPhase 2
Newark, Delaware
This trial is testing tarlatamab, a new medication aimed at treating solid tumors. It focuses on patients whose tumors may not respond well to other treatments. Tarlatamab works by helping the immune system recognize and destroy cancer cells.
Monoclonal Antibodies
Trastuzumab Deruxtecan for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Silver Spring, Maryland
This trial will compare the effectiveness and safety of Trastuzumab Deruxtecan to the current standard of care for treating non-small cell lung cancer with HER2 Exon 19 or 20 mutations.
Monoclonal Antibodies
ABBV-400 for Advanced Solid Cancers
Recruiting1 awardPhase 1
Fairfax, Virginia
This trial tests a new drug called ABBV-400 for adults with advanced cancers. The study aims to find the best dose and see how well it works, both alone and with other treatments. Patients will receive the drug through an IV and be closely monitored for effects and side effects.
Immunotherapy
ABBV-514 + Budigalimab for Lung & Head and Neck Cancers
Recruiting1 awardPhase 1
Fairfax, Virginia
This trial is testing two experimental drugs, ABBV-514 and Budigalimab, on adults with specific types of cancer. The goal is to find out if these drugs can help treat lung and head/neck cancers by monitoring their effects and side effects.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.